Oncogenetics
| S.No | Test Name | Sample Type | Sample Volume | Vacutainer | TAT* |
| 1 | Cancer Blood Karyotyping | Peripheral Blood | 3ml | Green top Sodium Heparin vacutainer | 2 weeks |
| 2 | Bone marrow Karyotyping | Bone marrow aspirate | 3ml | Green top Sodium Heparin vacutainer | 2 weeks |
| 3 | Chromosome breakage studies | Peripheral Blood | 3ml | Green top Sodium Heparin vacutainer | 2 weeks |
| 4 | Tumor or Lymph Karyotyping | Tumor biopsy | – | Sterile container – Normal saline | 2 weeks |
| 5 | bcr/abl (CML) FISH | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 6 | EGFR mutation (Lung small cell cancer) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 7 | Her 2 gene amplification (Breast Cancer) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 8 | Retinoblastoma | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 9 | Translocation 15/17 (PML/RARa for APL) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 10 | Translocation 8/14 (Burkitts, Lymphoma) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 11 | Translocation 8/21 (AML) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 12 | Translocation 11/14 | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 13 | Telvysion 1p (Meningioma and other tumors) | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
| 14 | Paint probe for chromosome 16 | Peripheral blood | 3ml | Green top Sodium Heparin vacutainer | 1 week |
Cancer Mutations Sequencing
| S.No | Disorder | Gene | Method | TAT* |
| 1 | Lung Cancer | EGFR / KRAS | Selected Exon Gene Sequencing | 2 weeks |
| 2 | JAK2 Mutation | JAK2 | Common Mutation Gene Sequencing | 2 weeks |
| 3 | Neuro Endocrine Carcinomaof Stomach and Liver | UGT1A1 | Common Mutation Gene Sequencing | 2 weeks |
| 4 | Multiple endocrine ,Neoplasia Type 1 | MEN1 | Common Mutation Gene Sequencing | 2 weeks |
| 5 | Multiple endocrine ,Neoplasia Type 2 | RET | Full Gene Sequencing | 2 weeks |
| 6 | bcr/abl – Qualitative | bcr/abl | RT PCR | 2 weeks |
| 7 | bcr/abl – Quantitative | bcr/abl | RQ RT PCR | 2 weeks |
| 8 | BRCA – Breast cancerPredisosition test | BRCA | Full Gene Sequencing | 2-3 weeks |
| 9 | PML/RARa – Qualitative | PML/RARa | RT PCR | 2 weeks |
| 10 | PML/RARa – Quantitative | PML/RARa | RQ RT PCR | 2 weeks |
| 11 | BRCA Gene Mutations | BRCA | Full Gene Sequencing | 2 weeks |
| 12 | Her/Neu | Her/Neu | RT PCR | 2 weeks |
| 13 | Micro array – Cancer Genes | Micro array | 4 weeks | |
| 14 | Other Cancer Mutations | Call |